Liposomal nano-drugs based on amphipathic weak acid steroid prodrugs for treatment of inflammatory diseases

References

• Rhen T , Cidlowski JA . Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 2005;353:1711–23.
   PubMed Web of Science ®Google Scholar
• Rock KL , Latz E , Ontiveros F , Kono H. The sterile inflammatory response. Annu Rev Immunol 2009;28:321–42.
   Web of Science ®Google Scholar
• Oschman JL. Chronic disease: are we missing something? J Altern Complement Med 2011;17:283–5.
   PubMed Web of Science ®Google Scholar
• Choy EH , Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis . N Engl J Med 2001;344:907–16.
   PubMed Web of Science ®Google Scholar
• Bonfield TL , Panuska JR , Konstan MW , et al . Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995;152:2111–8.
   PubMed Web of Science ®Google Scholar
• Ridker PM , Cushman M , Stampfer MJ , et al . Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men . N Engl J Med 1997;336:973–9.
   PubMed Web of Science ®Google Scholar
• Eizirik DL , Colli ML , Ortis F . The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 2009;5:219–26.
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS , Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006;6:813–22.
   PubMed Web of Science ®Google Scholar
• Youinou P , Pers J-O , Gershwin ME , Shoenfeld Y. Geo-epidemiology and autoimmunity. J Autoimmun 2010;34:J163–7.
   PubMed Web of Science ®Google Scholar
• Murphy KM , Travers P , Walport M. Janeway's immunobiology. New York (NY): Garland Science; 2012.
   Google Scholar
• Playfair JHL , Chain BM. Immunology at a glance. Hoboken, NJ: Wiley-Blackwell; 2012.
   Google Scholar
• Gillett N , Chan C. Applications of immunohistochemistry in the evaluation of immunosuppressive agents. Hum Exp Toxicol 2000;19:251–4.
   PubMed Web of Science ®Google Scholar
• de Lima Souza TRC , Marques GS , de Medeiros Vieira ACQ , de Freitas JCR. State of the art of anti-inflammatory drugs (Chap. 6). In: Badria F , ed. Pharmacotherapy. Rijeka, Croatia: InTech; 2012. p 115–140.
   Google Scholar
• Østensen M , Khamashta M , Lockshin M , et al . Anti-inflammatory and immunosuppressive drugs and reproduction . Arthritis Res Ther 2006;8:209–228.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Corticosteroids: the drugs to beat . Eur J Pharmacol 2006;533:2–14.
   PubMed Web of Science ®Google Scholar
• Pisetsky DS , Ward MM. Advances in the treatment of inflammatory arthritis. Best Pract Res Clin Rheumatol 2012;26:251–61.
   PubMed Web of Science ®Google Scholar
• Wood AJ , O'Dell JR. Therapeutic strategies for rheumatoid arthritis . N Engl J Med 2004;350:2591–602.
   PubMed Web of Science ®Google Scholar
• Yanovski JA , Cutler GB, Jr. Glucocorticoid action and the clinical features of Cushing's syndrome. Endocrinol Metab Clin North Am 1994;23:487–509.
   PubMed Web of Science ®Google Scholar
• Krakoff LR. Glucocorticoid excess syndromes causing hypertension. Cardiol Clin 1988;6:537–45.
   PubMedGoogle Scholar
• Hirschmann R. The cortisone era: aspects of its impact. Some contributions of the Merck laboratories. Steroids 1992;57:579–92.
   PubMed Web of Science ®Google Scholar
• Joseph B. The position not the presence of the halogen in corticosteroids influences potency and side effects. J Drugs Dermatol 2006;5:125–30.
   PubMedGoogle Scholar
• Coghlan MJ , Jacobson PB , Lane B , et al . A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects. Mol Endocrinol 2003;17:860–9.
   PubMed Web of Science ®Google Scholar
• Strehl C , Buttgereit F. Optimized glucocorticoid therapy: teaching old drugs new tricks. Mol Cell Endocrinol 2013;380:32–40.
   PubMed Web of Science ®Google Scholar
• Samtani MN , Lohle M , Grant A , et al . Betamethasone pharmacokinetics after two prodrug formulations in sheep: implications for antenatal corticosteroid use. Drug Metab Dispos 2005;33:1124–30.
   PubMed Web of Science ®Google Scholar
• Abma EM , Blanken R , De Heide LJ. Cushing's syndrome caused by topical steroid therapy for psoriasis. Neth J Med 2002;60:148–50.
   PubMed Web of Science ®Google Scholar
• Wicki J , Droz M , Cirafici L , Vallotton MB. Acute adrenal crisis in a patient treated with intraarticular steroid therapy. J Rheumatol 2000;27:510–1.
   PubMed Web of Science ®Google Scholar
• Singh R , Lillard JW, Jr. Nanoparticle-based targeted drug delivery. Exp Mol Pathol 2009;86:215–23.
   PubMed Web of Science ®Google Scholar
• LaVan DA , McGuire T , Langer R. Small-scale systems for in vivo drug delivery. Nat Biotechnol 2003;21:1184–91.
   PubMed Web of Science ®Google Scholar
• Kipp J. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int J Pharm 2004;284:109–22.
   PubMed Web of Science ®Google Scholar
• Kreuter J. Evaluation of nanoparticles as drug-delivery systems. II: comparison of the body distribution of nanoparticles with the body distribution of microspheres (diameter greater than 1 micron), liposomes, and emulsions. Pharm Acta Helv 1983;58:217–26.
   PubMedGoogle Scholar
• Barenholz Y. Liposomes: models for bilogical phenomena. In: Barenholz Y , Lasic D , eds. Handbook of nonmedical applications of liposomes. Boca Raton (FL): CRC Press; 1996.
   Google Scholar
• Gabizon A , Catane R , Uziely B , et al . Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 1994;54:987–92.
   PubMed Web of Science ®Google Scholar
• Gabizon A , Shmeeda H , Barenholz Y. Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Clin Pharmacokinet 2003;42:419–36.
   PubMed Web of Science ®Google Scholar
• Maeda H , Fang J , Inutsuka T , Kitamoto Y. Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int Immunopharmacol 2003;3:319–28.
   PubMed Web of Science ®Google Scholar
• Maeda H , Wu J , Sawa T , et al . Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000;65:271–84.
   PubMed Web of Science ®Google Scholar
• Greish K. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target 2007;15:457–64.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 2007;9:E128–47.
   PubMed Web of Science ®Google Scholar
• Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2003;2:347–60.
   PubMed Web of Science ®Google Scholar
• Maeda H , Bharate G , Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm 2009;71:409–19.
   PubMed Web of Science ®Google Scholar
• Shenoy V , Vijay I , Murthy R . Tumour targeting: biological factors and formulation advances in injectable lipid nanoparticles. J Pharm Pharmacol 2005;57:411–21.
   PubMed Web of Science ®Google Scholar
• Koo OM , Rubinstein I , Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine 2005;1:193–212.
   PubMed Web of Science ®Google Scholar
• Schiffelers RM , Koning GA , Ten Hagen TL , et al . Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. J Control Release 2003;91:115–22.
   PubMed Web of Science ®Google Scholar
• Gupta AS , Huang G , Lestini BJ , et al . RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system. Thromb Haemost 2005;93:106–14.
   PubMed Web of Science ®Google Scholar
• Chen X , Plasencia C , Hou Y , Neamati N. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery. J Med Chem 2005;48:1098–106.
   PubMed Web of Science ®Google Scholar
• Allen TM , Cullis PR. Drug delivery systems: entering the mainstream. Science 2004;303:1818–22.
   PubMed Web of Science ®Google Scholar
• Allen TM , Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 2013;65:36–48.
   PubMed Web of Science ®Google Scholar
• Barenholz YC . Doxil® – the first FDA-approved nano-drug: lessons learned. J Control Release 2012;160:117–34.
   PubMed Web of Science ®Google Scholar
• Boswell G , Buell D , Bekersky I. AmBisome (liposomal amphotericin B): a comparative review. J Clin Pharmacol 1998;38:583–92.
   PubMed Web of Science ®Google Scholar
• Lichtenberg D , Barenholz Y. Liposomes: preparation, characterization, and preservation. Methods Biochem Anal 1988;33:337–462.
   PubMedGoogle Scholar
• Mozafari MR. Liposomes: an overview of manufacturing techniques. Cell Mol Biol Lett 2005;10:711–9.
   PubMed Web of Science ®Google Scholar
• Crommelin DJ , Storm G. Liposomes: from the bench to the bed. J Liposome Res 2003;13:33–6.
   PubMed Web of Science ®Google Scholar
• Barenholz Y , Crommelin DJ. Liposomes as pharmaceutical dosage forms. In: Boylan JSAJC , ed. Encyclopedia of pharmaceutical technology. New York, Basel and Hong Kong: Marcel Dekker Inc; 1994:1–39.
   Google Scholar
• Barenholz Y. Relevancy of drug loading to liposomal formulation therapeutic efficacy. J Liposome Res 2003;13:1–8.
   PubMed Web of Science ®Google Scholar
• SciFinder Scholar 2006 software . Washington (DC): American Chemical Society; 2006.
   Google Scholar
• Gabizon A , Chisin R , Amselem S , et al . Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin. Br J Cancer 1991;64:1125–32.
   PubMed Web of Science ®Google Scholar
• Amselem S , Cohen R , Barenholz Y. In vitro tests to predict in vivo performance of liposomal dosage forms. Chem Phys Lipids 1993;64:219–37.
   PubMed Web of Science ®Google Scholar
• Mishina EV , Straubinger RM , Pyszczynski NA , Jusko WJ. Enhancement of tissue delivery and receptor occupancy of methylprednisolone in rats by a liposomal formulation. Pharm Res 1993;10:1402–10.
   PubMed Web of Science ®Google Scholar
• Shaw IH , Knight CG , Dingle JT. Liposomal retention of a modified anti-inflammatory steroid. Biochem J 1976;158:473–6.
   PubMed Web of Science ®Google Scholar
• Teshima M , Kawakami S , Fumoto S , et al . PEGylated liposomes loading palmitoyl prednisolone for prolonged blood concentration of prednisolone. Biol Pharm Bull 2006;29:1436–40.
   PubMed Web of Science ®Google Scholar
• Kumar VV. Complementary molecular shapes and additivity of the packing parameter of lipids. Proc Natl Acad Sci USA 1991;88:444–8.
   PubMed Web of Science ®Google Scholar
• Metselaar JM , Wauben MH , Wagenaar-Hilbers JP , et al . Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum 2003;48:2059–66.
   PubMed Web of Science ®Google Scholar
• Schmidt J , Metselaar JM , Wauben MH , et al . Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis. Brain 2003;126:1895–904.
   PubMed Web of Science ®Google Scholar
• Linker RA , Weller C , Lühder F , et al . Liposomal glucocorticosteroids in treatment of chronic autoimmune demyelination: long-term protective effects and enhanced efficacy of methylprednisolone formulations. Exp Neurol 2008;211:397–406.
   PubMed Web of Science ®Google Scholar
• Avnir Y , Turjeman K , Tulchinsky D , et al . Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoids. PloS One 2011;6:e25721.
   PubMed Web of Science ®Google Scholar
• Avnir Y , Ulmansky R , Wasserman V , et al . Amphipathic weak acid glucocorticoid prodrugs remote‐loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis. Arthritis Rheum 2008;58:119–29.
   PubMed Web of Science ®Google Scholar
• Moghimi SM , Hunter AC , Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001;53:283–318.
   PubMed Web of Science ®Google Scholar
• Kwon GS , Kataoka K. Block copolymer micelles as long-circulating drug vehicles. Adv Drug Deliv Rev 2012;64:237–45.
   Web of Science ®Google Scholar
• Müllner M , Dodds SJ , Nguyen T-H , et al . Size and rigidity of cylindrical polymer brushes dictate long circulating properties in vivo. ACS Nano 2015;9:1294–304.
   PubMed Web of Science ®Google Scholar
• Moghimi SM , Hunter AC. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. Trends Biotechnol 2000;18:412–20.
   PubMed Web of Science ®Google Scholar
• Boerman OC , Storm G , Oyen WJ , et al . Sterically stabilized liposomes labeled with indium-111 to image focal infection. J Nucl Med 1995;36:1639–44.
   PubMed Web of Science ®Google Scholar
• Boerman OC , Oyen WJ , van Bloois L , et al . Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time. J Nucl Med 1997;38:489–93.
   PubMed Web of Science ®Google Scholar
• Williams AS , Jones SG , Goodfellow RM , et al . Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritis. Br J Pharmacol 1999;128:234–40.
   PubMed Web of Science ®Google Scholar
• Bakker-Woudenberg IA , Ten Kate MT , Guo L , et al . Ciprofloxacin in polyethylene glycol-coated liposomes: efficacy in rat models of acute or chronic pseudomonas aeruginosa infection. Antimicrob Agents Chemother 2002;46:2575–81.
   PubMed Web of Science ®Google Scholar
• Cruz ME , Manuela Gaspar M , Barbara M , et al . Liposomal superoxide dismutases and their use in the treatment of experimental arthritis . Meth Enzymol 2005;391:395–413.
   PubMed Web of Science ®Google Scholar
• Barenholz YC. Doxil® – the first FDA-approved nano-drug: from basics via CMC, cell culture and animal studies to clinical use. Nanomedicines 2016;51:315–45.
   Google Scholar
• Metselaar JM , van den Berg WB , Holthuysen AE , et al . Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann Rheum Dis 2004;63:348–53.
   PubMed Web of Science ®Google Scholar
• Szebeni J , Baranyi L , Savay S , et al . Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies. J Liposome Res 2002;12:165–72.
   PubMed Web of Science ®Google Scholar
• Storm G , Oussoren C , Peeters PAM , Barenholz Y. Tolerability of liposomes in vivo. In: Gregoriadis G , ed. Liposome technology. 2nd ed. Boca-Raton (FL): CRC Press; 1993:345–83.
   Google Scholar
• Turjeman K , Bavli Y , Kizelsztein P , et al . Nano-drugs based on nano sterically stabilized liposomes for the treatment of inflammatory neurodegenerative diseases. PloS One 2015;10:e0130442.
   PubMed Web of Science ®Google Scholar
• Wei X , Cohen R , Barenholz Y. Insights into composition/structure/function relationships of Doxil® gained from “high-sensitivity” differential scanning calorimetry. Eur J Pharm Biopharm 2016;104:260–70.
   PubMed Web of Science ®Google Scholar
• Schilt Y , Berman T , Wei X , et al . Using solution X-ray scattering to determine the high-resolution structure and morphology of PEGylated liposomal doxorubicin nanodrugs. Biochim Biophys Acta 2016;1860:108–19.
   PubMed Web of Science ®Google Scholar
• Clerc S , Barenholz Y. A quantitative model for using acridine orange as a transmembrane pH gradient probe. Anal Biochem 1998;259:104–11.
   PubMed Web of Science ®Google Scholar
• Ramos S , Schuldiner S , Kaback HR. The electrochemical gradient of protons and its relationship to active transport in Escherichia coli membrane vesicles . Proc Natl Acad Sci USA 1976;73:1892–6.
   PubMed Web of Science ®Google Scholar
• Nichols JW , Deamer DW . Catecholamine uptake and concentration by liposomes maintaining p/ gradients. Biochim Biophys Acta 1976;455:269–71.
   PubMed Web of Science ®Google Scholar
• Madden TD , Harrigan PR , Tai LC , et al . The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey. Chem Phys Lipids 1990;53:37–46.
   PubMed Web of Science ®Google Scholar
• Haran G , Cohen R , Bar LK , Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim Biophys Acta 1993;1151:201–15.
   PubMed Web of Science ®Google Scholar
• Clerc S , Barenholz Y. Loading of amphipathic weak acids into liposomes in response to transmembrane calcium acetate gradients. Biochim Biophys Acta 1995;1240:257–65.
   PubMed Web of Science ®Google Scholar
• Zucker D , Marcus D , Barenholz Y , Goldblum A. Liposome drugs' loading efficiency: a working model based on loading conditions and drug's physicochemical properties. J Control Release 2009;139:73–80.
   PubMed Web of Science ®Google Scholar
• van der Valk FM , van Wijk DF , Lobatto ME , et al . Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration. Nanomedicine 2015;11:1039–46.
   PubMed Web of Science ®Google Scholar
• van den Hoven JM , Hofkens W , Wauben MH , et al . Optimizing the therapeutic index of liposomal glucocorticoids in experimental arthritis. Int J Pharm 2011;416:471–7.
   PubMed Web of Science ®Google Scholar
• Waknine-Grinberg JH , Even-Chen S , Avichzer J , et al . Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria. PloS One. 2013;8:e72722.
   Google Scholar
• Ulmansky R , Turjeman K , Baru M , et al . Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines. J Control Release 2012;160:299–305.
   PubMed Web of Science ®Google Scholar
• Moallem E , Koren E , Ulmansky R , et al . A liposomal steroid nano-drug for treating systemic lupus erythematosus. Lupus 2016;25:1209–16.
   PubMed Web of Science ®Google Scholar
• Allen T , Hansen C , Martin F , et al . Liposomes containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1991;1066:29–36.
   PubMed Web of Science ®Google Scholar
• Gabizon A , Shmeeda H , Barenholz Y . Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Clin Pharmacokinet 2003;42:419–36.
   PubMed Web of Science ®Google Scholar
• Papahadjopoulos D , Allen TM , Gabizon A , et al . Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci 1991;88:11460–4.
   PubMed Web of Science ®Google Scholar
• Crielaard B , Lammers T , Morgan M , et al . Macrophages and liposomes in inflammatory disease: friends or foes? Int J Pharm 2011;416:499–506.
   PubMed Web of Science ®Google Scholar
• Szebeni J , Bedőcs P , Rozsnyay Z , et al . Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome. Nanomedicine 2012;8:176–84.
   PubMed Web of Science ®Google Scholar
• Szebeni J , Muggia F , Barenholz Y. Case study: complement activation related hypersensitivity reactions to PEGylated liposomal doxorubicin, experimental and clinical evidence, mechanisms and approaches to inhibition. In: Dobrovolskaia MA , McNeil SE , eds. Handbook of immunological properties of engineered nanomaterials. Singapore: World Scientific; 2015.
   Google Scholar
• Szebeni J , Barenholz Y. Complement activation, immunogenicity, and immune suppression as potential side effects of liposomes. In: Dan Peer , ed. Handbook of harnessing biomaterials in nanomedicine: preparation, toxicity, and applications. Singapore: Pan Stanford Publishing Pte Ltd; 2012:309–34.
   Google Scholar
• Hadoke PW , Kipari T , Seckl JR , Chapman KE. Modulation of 11β-hydroxysteroid dehydrogenase as a strategy to reduce vascular inflammation. Curr Atheroscler Rep 2013;15:1–10.
   Web of Science ®Google Scholar
• Spann NJ , Garmire LX , McDonald JG , et al . Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 2012;151:138–52.
   PubMed Web of Science ®Google Scholar
• Hu W , Zhou X , Jiang M , et al . Statins synergize dexamethasone-induced adipocyte fatty acid binding protein expression in macrophages. Atherosclerosis 2012;222:434–43.
   PubMed Web of Science ®Google Scholar
• Szebeni J , Alving CR , Rosivall L , et al . Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles. J Liposome Res 2007;17:107–17.
   PubMed Web of Science ®Google Scholar
• Chanan-Khan A , Szebeni J , Savay S , et al . Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions. Ann Oncol 2003;14:1430–7.
   PubMed Web of Science ®Google Scholar
• Krishna M , Palme H , Duo J , et al . Development and characterization of antibody reagents to assess anti-PEG IgG antibodies in clinical samples. Bioanalysis 2015;7:1869–83.
   PubMed Web of Science ®Google Scholar
• Henry CE , Wang Y-Y , Yang Q , Hoang T , Chattopadhyay S , Hoen T , et al. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus. Acta Biomaterialia 2016;43:61–70.
   PubMed Web of Science ®Google Scholar
• Al‐Habet S , Rogers HJ. Methylprednisolone pharmacokinetics after intravenous and oral administration. Br J Clin Pharmacol 1989;27:285–90.
   PubMed Web of Science ®Google Scholar
• Rautio J , Kumpulainen H , Heimbach T , et al . Prodrugs: design and clinical applications. Nat Rev Drug Discov 2008;7:255–70.
   PubMed Web of Science ®Google Scholar
• Gold R , Linington C , Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006;129:1953–71.
   PubMed Web of Science ®Google Scholar
• Floris S , Blezer E , Schreibelt G , et al . Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain 2004;127:616–27.
   PubMed Web of Science ®Google Scholar
• Schleimer R , Spahn J , Covar R , Szefler S. Chapter 52. Glucocorticoids. In: Adkinson NF Jr , Yunginger WJ , Busse WW , Bochner SB , Holgate TS , et al., eds. Middleton’s allergy principles and practices. 6th ed. Philadelphia: Mosby, Inc; 2003:870–913.
   Google Scholar
• Gabizon AA , Barenholz Y , Bialer M. Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. Pharm Res 1993;10:703–8.
   PubMed Web of Science ®Google Scholar
• Waknine-Grinberg JH , Even-Chen S , Avichzer J , et al . Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria. PloS One 2013;8:e72722.
   PubMed Web of Science ®Google Scholar
• Deconinck N , Dan B. Pathophysiology of duchenne muscular dystrophy: current hypotheses. Pediatr Neurol 2007;36:1–7.
   PubMed Web of Science ®Google Scholar
• Stedman H , Sweeney H , Shrager J , et al . The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991;352:536–9.
   PubMed Web of Science ®Google Scholar
• Shaw I , Knight C , Dingle J. Liposomal retention of a modified anti-inflammatory steroid. Biochem J 1976;158:473–6.
   PubMed Web of Science ®Google Scholar
• Phillips NC , Thomas D , Knight CG , Dingle JT. Liposome-incorporated corticosteroids. II. Therapeutic activity in experimental arthritis. Ann Rheum Dis 1979;38:553–7.
   PubMed Web of Science ®Google Scholar
• Davidenkova E , Ternova N , Rozenberg O , et al . Relationship between prolongation of antiinflammatory activity of hydrocortisone incorporated into liposomes and their lipid composition in experimental arthritis. Bull Exp Biol Med 1984;97:716–8.
   Web of Science ®Google Scholar
• Schmidt J , Metselaar JM , Gold R. Intravenous liposomal prednisolone downregulates in situ TNF-a production by T-cells in experimental autoimmune encephalomyelitis. J Histochem Cytochem 2003;51:1241–4.
   PubMed Web of Science ®Google Scholar
• Parmar J , Singh D , Hegde DD , et al . Development and evaluation of inhalational liposomal system of budesonide for better management of asthma. Indian J Pharmaceut Sci 2010;72:442.
   PubMed Web of Science ®Google Scholar
• Hofkens W , Storm G , Van Den Berg W , Van Lent P. Liposomal targeting of glucocorticoids to the inflamed synovium inhibits cartilage matrix destruction during murine antigen-induced arthritis. Int J Pharmaceut 2011;416:486–92.
   PubMed Web of Science ®Google Scholar
• Hofkens W , Grevers LC , Walgreen B , et al . Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis. J Controlled Release 2011;152:363–9.
   PubMed Web of Science ®Google Scholar
• Metselaar J , Van den Berg W , Holthuysen A , et al . Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann Rheum Dis 2004;63:348–53.
   PubMed Web of Science ®Google Scholar
• Bonanomi M , Velvart M , Stimpel M , et al . Studies of pharmacokinetics and therapeutic effects of glucocorticoids entrapped in liposomes after intraarticular application in healthy rabbits and in rabbits with antigen-induced arthritis. Rheumatol Int 1987;7:203–12.
   PubMed Web of Science ®Google Scholar
• Koning GA , Schiffelers RM , Wauben MH , et al . Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. Arthritis Rheum 2006;54:1198–208.
   PubMed Web of Science ®Google Scholar
• Rauchhaus U , Schwaiger F-W , Panzner S. Separating therapeutic efficacy from glucocorticoid side-effects in rodent arthritis using novel, liposomal delivery of dexamethasone phosphate: long term suppression of arthritis facilitates interval treatment. Arthritis Res Therapy 2009;11:1–9.
   Web of Science ®Google Scholar
• Hofkens W , van den Hoven JM , Pesman GJ , et al . Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: comparison of prednisolone with budesonide. Int J Pharmaceut 2011;416:493–8.
   PubMed Web of Science ®Google Scholar
• Konduri KS , Nandedkar S , Düzgünes N , et al . Efficacy of liposomal budesonide in experimental asthma. J Allergy Clin Immunol 2003;111:321–7.
   PubMed Web of Science ®Google Scholar
• Waldrep JC , Keyhani K , Black M , Knight V. Operating characteristics of 18 different continuous-flow jet nebulizers with beclomethasone dipropionate liposome aerosol. CHEST J 1994;105:106-10.
   PubMed Web of Science ®Google Scholar